Mariam Haji, Zunairah Shah, Han Yu, Sheheryar Kairas Kabraji. "Real-world analysis of adjuvant abemaciclib in high-risk HR+/HER2− early breast cancer.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.e12529